Searching for Answers in GRID Radiation: A Sarcoma Patient's Story

A treatment approach known as GRID radiation has been used for years, but researchers still don't fully understand why some patients experience remarkable responses. At UNC Lineberger Comprehensive Cancer Center, a team of scientists is leading the first human study of GRID therapy in sarcoma. The trial is evaluating whether the treatment is safe and effective while also analyzing tumor tissue after treatment to better understand how GRID works—including whether it stimulates an immune response that helps destroy cancer cells. Hear from a UNC Health physician and physicist working together to answer that question, as well as a sarcoma patient who chose to participate in the study in hopes of helping future patients like her.